St. Vincent’s Riverside First in the Region to Offer Transcatheter Aortic Valve Replacement Therapy |

Title (Max 100 Characters)

St. Vincent’s Riverside First in the Region to Offer Transcatheter Aortic Valve Replacement Therapy

St. Vincent’s Medical Center Riverside has been selected by Edwards Lifesciences as the first hospital in the region to offer patients transcatheter aortic valve replacement (TAVR) therapy. There are only thirteen other hospitals in the state of Florida offering this life saving technology.

“St. Vincent’s has always been considered a leader in the field of cardiology. Edwards Lifesciences has carefully hand selected cardiovascular programs across the country that have a highly skilled multidisciplinary team and a history of providing high quality and innovative care to patients. We are excited to bring this technology to the citizens of Northeast Florida and Southeast Georgia,” said Moody Chisholm, CEO of St. Vincent’s HealthCare.

TAVR was approved by the Food and Drug Administration in 2011 for patients with severe aortic valve stenosis or severe narrowing of aortic valves.

“These patients were previously deemed inoperable by cardiac surgeons so this procedure is offering some of our sickest patients a second lease on life,” said Samer Garas, MD, Diagnostic Cardiology Associates.

The TAVR procedure requires a multidisciplinary approach in a special operating room called a Hybrid O-R. St. Vincent’s Riverside just finished construction on its new 860 sq. ft. Hybrid O-R. An average operating room is 400 sq. ft. but this one is more than double the size to accommodate the larger team and equipment needed for the procedure. Cardiothoracic surgeons and Interventionalists rarely have the opportunity to work so closely together… but for these cases a team approach becomes necessary.

The team will deploy the Edwards SAPIEN valve through the femoral artery in the thigh. Previously patients needed open heart surgery to replace these diseased valves. The surgeon and his team are there to take immediate action if necessary.

“Our goal is to keep this procedure a minimally invasive one, but in the event surgery becomes necessary my team is on standby. This Hybrid O-R was designed to be able to handle interventional and surgical cases,” said Mark Mostovych, MD, Cardiothoracic & Vascular Surgical Associates.

St. Vincent’s anticipates it will perform its first TAVR procedure in early September.

Avondale - Riverside Businesses